[ Price : $8.95]
FDA approves a GlaxoSmithKline BLA for Fluarix Quadrivalent (influenza virus vaccine) for the immunization of children (three year...[ Price : $8.95]
A new Congressional Research Service report on FDAs biosimilars pathway finds that navigating the approval path will be an arduous...[ Price : $8.95]
FDA grants fast track status to Lexicon Pharmaceuticals for LX1033, an orally-delivered small molecule drug candidate for diarrhea...[ Price : $8.95]
Three months ahead of its user fee review date, FDA approves an Ariad Pharmaceuticals NDA for Iclusig to treat adults with two for...[ Price : $8.95]
FDA approves Human Genome Sciences raxibacumab injection to treat inhalational anthrax.[ Price : $8.95]
FDA commissioner Margaret Hamburg says that that if academia, industry, government scientists and regulators could come together m...[ Price : $8.95]
Representatives from FDA, the Centers for Medicare and Medicaid Services and Department of Justice discuss policy considerations a...[ Price : $8.95]
FDA accepts an Actelion NDA for Opsumit (macitentan), indicated for treating patients with pulmonary arterial hypertension.